Phase 11 — Psychoneuroimmunology, Epigenomics, Neuroimmune Programming & Disease-Modulation Framework
Program: PROJECT STRANDSHIFT
Classification: Trauma Biology × Epigenomics × Neuroimmunology × HTT Disease-Modifier Atlas
Scientific Domain: Psychoneuroimmunology (PNI), Epigenetics, Neuroimmunology, Stress Biology, Neurodegeneration, Systems Pathophysiology
Primary Objective:
To construct a comprehensive systems-level atlas describing how psychological trauma, chronic stress exposure, neuroendocrine signaling, epigenetic remodeling, immune programming, neuroimmune activation, DNA injury responses, and disease resilience interact within Huntington disease and HTT-associated neurodegenerative disorders.
EXECUTIVE SUMMARY
The Trauma–Epigenomic Convergence Atlas addresses a central STRANDSHIFT question:
Can trauma-associated biological programming alter disease trajectory without altering the inherited HTT mutation itself?
Within the STRANDSHIFT framework:
- HTT mutation remains the initiating genetic event.
- Trauma is not considered a cause of Huntington disease.
- Trauma-associated biological adaptations may modify disease expression.
- Epigenetic remodeling may influence immune behavior, stress physiology, neuroinflammatory burden, and resilience capacity.
The atlas therefore examines how life experiences may become biologically embedded through epigenetic mechanisms and subsequently influence neuroimmune and neurodegenerative processes.
CENTRAL STRANDSHIFT TRAUMA HYPOTHESIS
Core Hypothesis
Trauma exposure may create long-term biological programming patterns through epigenetic remodeling.
These programs may influence:
- HPA-axis responsiveness
- Neuroimmune activation
- Cytokine production
- Mitochondrial function
- DNA repair efficiency
- Viral-mimicry susceptibility
- Apoptotic thresholds
without changing the underlying HTT mutation.
SCF–CMF TRAUMA CONVERGENCE MODEL
Within the Conscience Mind Framework:
CMF Domain | Trauma Biology Translation |
Awareness | Threat perception and environmental appraisal |
Emotion | Limbic stress processing |
Embodiment | Neuroendocrine and autonomic adaptation |
Energy | Mitochondrial adaptation and metabolic burden |
Time | Persistence of biological memory |
Transformation | Recovery, resilience, or maladaptive programming |
The atlas proposes that trauma-associated biological effects emerge through long-term incompatibilities across these domains.
TRAUMA–EPIGENOMIC FAULT ARCHITECTURE
Tier I — Trauma Exposure Layer
Primary Inputs
- Early-life adversity
- Chronic psychological stress
- Repeated trauma
- Social isolation
- Caregiver stress
- Sleep disruption
- Chronic uncertainty
Outputs
- HPA-axis activation
- Sympathetic activation
- Behavioral adaptation
CMF Domain
Awareness
Tier II — Neuroendocrine Adaptation Layer
Primary Systems
- Hypothalamus
- Pituitary
- Adrenal axis
- Autonomic nervous system
Outputs
- Cortisol
- ACTH
- Catecholamines
- Neurosteroids
CMF Domains
Emotion → Embodiment
Tier III — Epigenomic Remodeling Layer
Primary Mechanisms
- DNA methylation
- Histone modification
- Chromatin accessibility
- Non-coding RNA regulation
Outputs
- Altered gene expression programs
- Persistent biological memory
CMF Domain
Time
Tier IV — Immune Programming Layer
Primary Systems
- Monocytes
- Macrophages
- Microglia
- T lymphocytes
Outputs
- Cytokine production profiles
- Trained immunity states
- Neuroimmune responsiveness
Tier V — Neuroimmune Activation Layer
Outputs
- Chronic inflammation
- Cytokine amplification
- Microglial priming
CMF Domain
Transformation
TRAUMA EPIGENETIC SIGNATURE ATLAS
NR3C1 (Glucocorticoid Receptor)
Molecular Function
Master glucocorticoid signaling receptor.
Trauma-Associated Epigenetic Signature
Increased promoter methylation has been associated in some studies with altered stress responsivity.
STRANDSHIFT Interpretation
Potential regulator of long-term HPA-axis sensitivity.
FKBP5
Molecular Function
Glucocorticoid receptor co-chaperone.
Trauma Signature
Stress-responsive epigenetic remodeling may alter FKBP5 expression.
STRANDSHIFT Interpretation
Candidate mediator of chronic stress adaptation.
CRH
Molecular Function
Initiates HPA-axis activation.
Epigenetic Relevance
Stress-responsive chromatin remodeling.
Interpretation
Central stress-programming node.
SLC6A4
Molecular Function
Serotonin transporter.
Epigenetic Relevance
Stress-associated methylation changes reported in multiple populations.
Interpretation
Emotion-processing adaptation marker.
IMMUNE PROGRAMMING GENE ATLAS
IL6
Physiological Function
Pro-inflammatory cytokine.
Trauma Programming Role
Potential persistent inflammatory sensitization.
STRANDSHIFT Interpretation
Neuroimmune amplification marker.
TNF
Physiological Function
Inflammatory signaling mediator.
Programming Role
Chronic inflammatory responsiveness.
Interpretation
Stress-inflammation convergence marker.
IL1B
Physiological Function
Innate immune activation.
Programming Role
Enhanced inflammatory responsiveness.
Interpretation
Microglial priming marker.
NFKB1
Molecular Function
Master inflammatory transcription factor.
Programming Role
Inflammatory memory architecture.
Interpretation
Central immune-programming regulator.
MICROGLIAL MEMORY ATLAS
Concept
Microglia may develop long-lasting alterations in responsiveness following repeated inflammatory exposure.
Homeostatic State
Markers:
- P2RY12
- TMEM119
Functions:
- surveillance
- repair
Primed State
Markers:
- TREM2
- CD68
- HLA-DR
Functions:
- increased responsiveness
- enhanced cytokine production
Chronic Reactive State
Markers:
- IL1B
- TNF
- NLRP3
Functions:
- sustained neuroinflammation
TRAUMA–DNA INJURY CONVERGENCE
Proposed Model
Trauma Exposure
↓
Stress Signaling
↓
Cortisol Dysregulation
↓
Mitochondrial Stress
↓
ROS Generation
↓
DNA Injury
↓
Repair-System Engagement
↓
Potential Genomic Vulnerability
DNA Injury Markers
Marker | Interpretation |
γH2AX | DNA break burden |
53BP1 | Repair engagement |
ATM | DNA damage sensing |
ATR | Replication stress |
PARP1 | Repair workload |
8-OHdG | Oxidative DNA injury |
TRAUMA–VIRAGENESIS CONVERGENCE MODEL
Theoretical Pathway
Trauma
↓
Stress Programming
↓
Immune Dysregulation
↓
Interferon Imbalance
↓
cGAS-STING Sensitization
↓
Viral Mimicry Susceptibility
↓
Neuroimmune Amplification
This remains a theoretical framework requiring validation.
EPIGENETIC REGULATORY SYSTEMS
DNA Methylation Layer
Primary Function:
Long-term gene-expression regulation.
Targets:
- NR3C1
- FKBP5
- SLC6A4
- BDNF
Histone Modification Layer
Primary Function:
Chromatin accessibility regulation.
Targets:
- inflammatory genes
- stress-response genes
- repair-associated genes
Non-Coding RNA Layer
microRNAs
Potential Targets:
- cytokine regulation
- apoptosis regulation
- mitochondrial pathways
Long Non-Coding RNAs
Potential Roles:
- immune regulation
- chromatin remodeling
- neurodegenerative signaling
IMMUNE PROGRAMMING STATES
State I — Adaptive Resilience
Characteristics:
- balanced cytokines
- efficient recovery
- preserved neuroplasticity
State II — Compensated Stress Adaptation
Characteristics:
- mild inflammatory elevation
- preserved function
State III — Neuroimmune Sensitization
Characteristics:
- elevated IL-6
- elevated TNF
- microglial priming
State IV — Chronic Neuroimmune Activation
Characteristics:
- persistent inflammation
- impaired recovery
State V — Neurodegenerative Amplification
Characteristics:
- apoptosis susceptibility
- neuroimmune escalation
- disease acceleration
TRAUMA–EPIGENOMIC INDICES
Trauma Epigenomic Burden Index (TEBI)
Measures:
- NR3C1 methylation
- FKBP5 remodeling
- stress-associated epigenetic signatures
Purpose:
Quantifies biological trauma imprinting.
Immune Programming Index (IPI)
Measures:
- IL6
- TNF
- IL1B
- NFKB activity
Purpose:
Quantifies inflammatory programming.
Microglial Priming Index (MPI)
Measures:
- TREM2
- CD68
- HLA-DR
- NLRP3
Purpose:
Measures neuroimmune sensitization.
Trauma–DNA Injury Index (TDII)
Measures:
- cortisol
- γH2AX
- 53BP1
- 8-OHdG
Purpose:
Measures convergence between trauma biology and genomic stress.
Trauma–Viragenesis Susceptibility Index (TVSI)
Measures:
- IFN signatures
- OAS1
- MX1
- ISG15
- cGAS-STING activity
Purpose:
Measures vulnerability to maladaptive antiviral-state activation.
STRANDSHIFT RESEARCH QUESTIONS
Question 1
Can trauma-associated epigenetic signatures predict future neuroimmune activation?
Prediction
Higher TEBI scores will correlate with higher MPI and IPI scores.
Question 2
Do trauma-associated immune programs increase susceptibility to chronic neuroinflammation?
Prediction
Persistent inflammatory programming will correlate with elevated neuroimmune burden.
Question 3
Can trauma-associated biological programming influence DNA injury accumulation?
Prediction
Higher TDII scores will associate with greater DNA repair burden.
Question 4
Does trauma alter viral-mimicry susceptibility?
Prediction
Higher TVSI scores may correlate with stronger interferon-associated signaling.
Question 5
Can trauma-associated programming influence disease resilience?
Prediction
Lower resilience states will associate with higher inflammatory and neuroimmune indices.
Question 6
Can epigenetic signatures identify individuals at increased risk for accelerated disease progression?
Prediction
Integrated TEBI, MPI, and TDII profiles may stratify disease-modifier risk.
Question 7
Can biological resilience reverse maladaptive immune programming?
Prediction
Improvement in sleep, circadian stability, stress regulation, physical activity, and social connectedness may associate with lower neuroimmune burden over time.
SCF–CMF INTERPRETATION
Within the Synergistic Compatibility Framework, trauma is viewed as a biological compatibility challenge rather than a deterministic disease driver.
The Conscience Mind Framework proposes that:
Awareness
↓
Emotion
↓
Embodiment
↓
Energy
↓
Time
↓
Transformation
creates a continuous feedback architecture through which experiences become biologically embedded.
The Trauma–Epigenomic Convergence Atlas therefore hypothesizes that trauma-associated biological memory may influence neuroimmune behavior, inflammatory programming, and resilience capacity, thereby modifying the trajectory of HTT-associated disease without altering the underlying genetic mutation.
CONCLUSION
The Trauma–Epigenomic Convergence Atlas establishes the psychoneuroimmunological and epigenomic layer of PROJECT STRANDSHIFT. It provides a structured framework for investigating how trauma-associated biological programming, stress-responsive epigenetic remodeling, immune-memory systems, microglial priming, DNA injury responses, and viral-mimicry pathways may interact with the primary HTT disease process.
The atlas positions trauma-related biology as a potential disease-modifier system that can be measured, modeled, and tested through longitudinal multi-omic, neuroimmune, epigenomic, and clinical studies.